National Institute for Health and Care Excellence8h
In consultation: Guidance and quality standards
Health inequalities modular update to NICE health technology evaluations: the manual (PMG36) Methods / process manual consultation NICE process and methods 31 January 2025 Highly specialised ...
National Institute for Health and Care Excellence3d
Vibostolimab–pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID6382]
A list of downloadable documents created during development.
National Institute for Health and Care Excellence3d
Vibostolimab–pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID6382]
The Department of Health has asked NICE to produce guidance on using the above technology in the NHS in England. The company has informed NICE that it will not provide an evidence submission for this ...
National Institute for Health and Care Excellence3d
Pembrolizumab–vibostolimab for untreated metastatic non-small-cell lung cancer [ID6365]
The Department of Health has asked NICE to produce guidance on using the above technology in the NHS in England. The company has informed NICE that it will not provide an evidence submission for this ...
National Institute for Health and Care Excellence3d
Pembrolizumab–vibostolimab for untreated metastatic non-small-cell lung cancer [ID6365]
A list of downloadable documents created during development.